Skip to main content
Premium Trial:

Request an Annual Quote

BGI to use CLC Bio's Sequencing Analysis Software

NEW YORK (GenomeWeb News) – The Beijing Genomics Institute has licensed CLC bio’s sequencing analysis and visualization software, CLC bio said today.
 
The site license agreement for CLC bio’s Genomics Workbench allows all BGI researchers to use the software in all of its sites, inside and outside of China.
 
The Aarhus, Denmark-based company said BGI will use the software in its daily research, which includes projects such as the Giant Panda Genome Project and the 1000 Genomes Project.
 
BGI has 17 Illumina Genome Analyzers, two ABI SOLiD sequencers, and three Roche 454 sequencers in its next-generation sequencing tool shed.
 
CLC said the Workbench utilizes paired end data and supports tasks including reference assembly, de novo assembly, SNP detection, multiplexing, and high-throughput trimming.
 
Financial terms of the agreement were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.